US OptionsDetailed Quotes
RIGL241220P10000
- 0.40
- 0.000.00%
15min DelayTrading Sep 26 14:08 ET
0.00High0.00Low
0.00Open0.40Pre Close0 Volume12 Open Interest10.00Strike Price0.00Turnover381.92%IV48.99%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.40Extrinsic Value100Contract SizeAmericanOptions Type-0.0714Delta0.0136Gamma47.05Leverage Ratio-0.0952Theta-0.0003Rho-3.36Eff Leverage0.0036Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet